Huimin Lu

机构：Harbin Medical University, Sir Run Run Shaw Hospital · ORCID：0000-0002-4972-0899

发表论文 123 篇 · 总被引 3108 次 · h-index 33

代表论文

• Neutralizing IL-8 potentiates immune checkpoint blockade efficacy for glioma (2023 · Cancer Cell · 被引 144)
• EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma (2022 · Signal Transduction and Targeted Therapy · 被引 72)
• Revisiting the Role of Valeric Acid in Manipulating Ulcerative Colitis (2024 · Inflammatory Bowel Diseases · 被引 35)
• Inhibitory effects of temozolomide on glioma cells is sensitized by RSL3-induced ferroptosis but negatively correlated with expression of ferritin heavy chain 1 and ferritin light chain (2022 · Laboratory Investigation · 被引 33)
• RIPK1 inhibitor ameliorates pulmonary injury by modulating the function of neutrophils and vascular endothelial cells (2024 · Cell Death Discovery · 被引 19)
• Nanoparticle encapsulated CQ/TAM combination harmonizes with MSCs in arresting progression of severity in AP mice through iNOS (IDO) signaling (2022 · Materials Today Bio · 被引 11)